ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

CMS Final Rule Imposes 6 Percent Cut On Physician Fees Over Four Years

November 6, 2009

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

In Brief: Senate Subcommittee Includes $2.7 Billion Increase for NIH in Budget Bill Markup

May 12, 2000

ACS Awards Professorships To Brugge, Hanahan, Samson; Renews Verma, Wigler.

February 9, 2001

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

January 3, 1992